Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Real-World Evidence, Multicenter Study to Evaluate the Efficacy and Safety of Eslicarbazepine in Managing Epilepsy

NCT07793396 is registered in ClinicalTrials.gov with King Edward Medical University as lead sponsor.

NCT NCT07793396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07793396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Real-World Evidence, Multicenter Study to Evaluate the Efficacy and Safety of Eslicarbazepine in Managing Epilepsy
Lead sponsor
King Edward Medical University
Phase
Observational
Overall status
Recruiting
Start date
December 2, 2025
Completion date
December 31, 2026
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

focal-onset seizures